Lv21
130 积分 2023-03-24 加入
Progress towards the development of SH2 domain inhibitors
7小时前
已完结
JAK/STAT inhibitors for the treatment of atopic dermatitis
8小时前
已完结
Turning Off STAT6 with a Targeted Degrader
12小时前
已完结
Optimization of a Series of RIPK2 PROTACs
27天前
已完结
Challenges and Opportunities for In Vivo PROTAC Delivery
27天前
已完结
In vitro and in vivo degradation of programmed cell death ligand 1 (PD-L1) by a proteolysis targeting chimera (PROTAC)
27天前
已完结
Discovery of AK-1690: A Potent and Highly Selective STAT6 PROTAC Degrader
1个月前
已完结
A Novel Inhalable Nanobody Targeting IL-4Rα for the Treatment of Asthma
1个月前
已完结
Dupilumab reduces inflammatory biomarkers in pediatric patients with moderate-to-severe atopic dermatitis
1个月前
已完结
Chasing molecular glue degraders: screening approaches
1个月前
已完结
皖公网安备34019202002308
